Vireo Health International (CSE: VREO) (OTCQX: VREOF) - Investor Dashboard

Vireo Health
CSE Ticker: VREO
Market Focus: United States
Classification: Vertically Integrated
Country: United States
Employees: 477 (March 2021)
Established: 2012
CEO: Kyle Kingsley, M.D.

Vireo – Cannabis Brands and Intellectual Property Portfolio

Vireo’s retail outlets are being transformed and rebranded to “Green Goods” dispensaries

Which will feature an inviting health and wellness environment, focused on personalized service. The retail outlets will stock only the highest quality, safest products that have been selected by Vireo medical and scientific teams Multiple ordering and fulfillment options for customers, including in-store pick-up, self-ordering stations and home delivery “Knowledge Bar” for patients and adult-use consumers seeking expert information from onsite pharmacists and trained professionals

Real Intellectual Property: Current Portfolio

Short-Term Monetization

  • Cannabis Moist Snuff Composition
  • Multi-Channel Vaporizer
  • Non-Cannabinoid Negative Control Formulations (Placebo)
  • Proprietary Inflorescence Packaging
  • Scaled Cannabis Processing Equipment
  • Proprietary Concentrate Delivery Method
  • Front-to-Back Home Delivery System

Long-Term Applications

  • Harm Reduction Additive for Tobacco Products
  • Method for Treating Antidepressant Withdrawal Syndrome
  • Captisol-Enabled Intravenous Cannabinoid Formulations
  • Custom Extract Dispenser

Visit Vireo Health International, Inc.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Vireo Health International, Inc. is a client of NCV Media, LLC. Read our full disclaimer.